110 related articles for article (PubMed ID: 18625225)
1. PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma.
Wang C; Xiao Y; Hu Z; Chen Y; Liu N; Hu G
FEBS Lett; 2008 Aug; 582(18):2793-8. PubMed ID: 18625225
[TBL] [Abstract][Full Text] [Related]
2. PEG10 is a c-MYC target gene in cancer cells.
Li CM; Margolin AA; Salas M; Memeo L; Mansukhani M; Hibshoosh H; Szabolcs M; Klinakis A; Tycko B
Cancer Res; 2006 Jan; 66(2):665-72. PubMed ID: 16423995
[TBL] [Abstract][Full Text] [Related]
3. [The imprinting status of genetic imprinted gene PEG10 in human hepatocellular carcinomas].
Gao Y; Zhang HD; Lin JS; Zhang MP; Zhang RG
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):894-9. PubMed ID: 21205473
[TBL] [Abstract][Full Text] [Related]
4. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.
Jie X; Lang C; Jian Q; Chaoqun L; Dehua Y; Yi S; Yanping J; Luokun X; Qiuping Z; Hui W; Feili G; Boquan J; Youxin J; Jinquan T
Oncogene; 2007 Aug; 26(39):5741-51. PubMed ID: 17369855
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma.
Huang J; Zhang X; Zhang M; Zhu JD; Zhang YL; Lin Y; Wang KS; Qi XF; Zhang Q; Liu GZ; Yu J; Cui Y; Yang PY; Wang ZQ; Han ZG
Carcinogenesis; 2007 May; 28(5):1094-103. PubMed ID: 17114643
[TBL] [Abstract][Full Text] [Related]
6. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.
Ip WK; Lai PB; Wong NL; Sy SM; Beheshti B; Squire JA; Wong N
Cancer Lett; 2007 Jun; 250(2):284-91. PubMed ID: 17126992
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells.
Real PJ; Sanz C; Gutierrez O; Pipaon C; Zubiaga AM; Fernandez-Luna JL
FEBS Lett; 2006 Oct; 580(25):5905-9. PubMed ID: 17027756
[TBL] [Abstract][Full Text] [Related]
8. PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.
Tsuji K; Yasui K; Gen Y; Endo M; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
Cancer Genet Cytogenet; 2010 Apr; 198(2):118-25. PubMed ID: 20362226
[TBL] [Abstract][Full Text] [Related]
9. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
10. [MiR-122 regulates the expression of PEG10 in hepatoma cell lines].
Chang Y; He XX; Li PY; Lin JS
Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):288-91. PubMed ID: 20460050
[TBL] [Abstract][Full Text] [Related]
11. Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients.
Sakai Y; Honda M; Fujinaga H; Tatsumi I; Mizukoshi E; Nakamoto Y; Kaneko S
Cancer Res; 2008 Dec; 68(24):10267-79. PubMed ID: 19074895
[TBL] [Abstract][Full Text] [Related]
12. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers.
Tsou AP; Chuang YC; Su JY; Yang CW; Liao YL; Liu WK; Chiu JH; Chou CK
J Biomed Sci; 2003; 10(6 Pt 1):625-35. PubMed ID: 14576465
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of hTERT promoter in hepatocellular carcinomas.
Iliopoulos D; Satra M; Drakaki A; Poultsides GA; Tsezou A
Int J Oncol; 2009 Feb; 34(2):391-9. PubMed ID: 19148473
[TBL] [Abstract][Full Text] [Related]
18. Promising roles of mammalian E2Fs in hepatocellular carcinoma.
Zhan L; Huang C; Meng XM; Song Y; Wu XQ; Miu CG; Zhan XS; Li J
Cell Signal; 2014 May; 26(5):1075-81. PubMed ID: 24440307
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
20. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
Yeh MH; Kao ST; Hung CM; Liu CJ; Lee KH; Yeh CC
Toxicol Lett; 2009 Feb; 184(3):204-10. PubMed ID: 19110045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
